Lack of Association Between the C276T Polymorphism of the Neuronal Nitric Oxide Synthase Gene and Migraine

REFERENCES

• Bigal ME, Rapoport AM, Lipton RB, Tepper SJ, Sheftell FD. Assessment of migraine disability using the migraine disability assessment (MIDAS) questionnaire: a comparison of chronic migraine with episodic migraine. Headache. 2003;43:336–42.
   PubMedGoogle Scholar
• Headache Classification Subcommittee of the International Headache Society. The International classification of headache disorders: 2nd edition. Cephalalgia. 2004;24:9–160.
   PubMedGoogle Scholar
• McCann SM. The nitric oxide hypothesis of brain aging. Exp Gerontol. 1997;32:431–40.
   PubMedGoogle Scholar
• Bredt DS. Endogenous nitric oxide synthesis: biological functions and pathophysiology. Free Radic Res. 1999;31: 577–96.
   PubMedGoogle Scholar
• Moncada S, Palmer RM, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev. 1991; 43:109–42.
   PubMedGoogle Scholar
• Thomsen LL, Olesen J. Nitric oxide theory of migraine. Clin Neurosci. 1998;5:28–33.
   PubMedGoogle Scholar
• Olesen J, Thomsen LL, Lassen LH, Olesen IJ. The nitric oxide hypothesis of migraine and other vascular headaches. Cephalalgia. 1995;15:94–100.
   PubMedGoogle Scholar
• Moskowitz MA. Neurogenic inflammation in the pathophysiology and treatment of migraine. Neurology. 1993;43:S16–20.
   PubMedGoogle Scholar
• Shukla R, Barthwal MK, Srivastava N, Nag D, Seth PK, Srimal RC, Dikshit M. Blood nitrite levels in patients with migraine during headache-free period. Headache. 2001;41:475–81.
   PubMedGoogle Scholar
• Sarchielli P, Alberti A, Codini M, Floridi A, Gallai V. Nitric oxide metabolites, prostaglandins and trigeminal vasoactive peptides in internal jugular vein blood during spontaneous migraine attacks. Cephalalgia. 2000;20: 07–918.
   Google Scholar
• Olesen J, Iversen HK, Thomsen LL. Nitric oxide supersensitivity: a possible molecular mechanism of migraine pain. Neuroreport. 1993;4:1027–30.
   PubMedGoogle Scholar
• Lassen LH, Thomsen LL, Olesen J. Histamine induces migraine via the H1-receptor. Support for the NO hypothesis of migraine. Neuroreport. 1995;6:1475–9.
   PubMedGoogle Scholar
• Lassen LH, Thomsen LL, Kruuse C, Iversen HK, Olesen J. Histamine-1 receptor blockade does not prevent nitroglycerin induced migraine. Support for the NO-hypothesis of migraine. Eur J Clin Pharmacol. 1996;49:335–9.
   PubMedGoogle Scholar
• Read SJ, Manning P, McNeil CJ, Hunter AJ, Parsons AA. Effects of sumatriptan on nitric oxide and superoxide balance during glyceryl trinitrate infusion in the rat. Implications for antimigraine mechanisms. Brain Res. 1999;847:1–8.
   PubMedGoogle Scholar
• Lassen LH, Ashina M, Christiansen I, Ulrich V, Grover R, Donaldson J, Olesen J. Nitric oxide synthase inhibition: a new principle in the treatment of migraine attacks. Cephalalgia. 1998;18:27–32.
   PubMedGoogle Scholar
• Blum-Degen D, Heinemann T, Lan J, Pedersen V, Leblhuber F, Paulus W, Riederer P, Gerlach M. Characterization and regional distribution of nitric oxide synthase in the human brain during normal ageing. Brain Res. 1999;834: 128–35.
   PubMedGoogle Scholar
• Kishimoto J, Spurr N, Liao M, Lizhi L, Emson P, Xu W. Localization of brain nitric oxide synthase (NOS) to human chromosome 12. Genomics. 1992;14(Suppl 3):802–4. Erratum in: Genomics 1993;15:465.
   PubMedGoogle Scholar
• Stam AH, Haan J, van den Maagdenberg AM, Ferrari MD, Terwindt GM. Migraine and genetic and acquired vasculopathies. Cephalalgia. 2009;29:1006–17.
   PubMedGoogle Scholar
• de Vries B, Frants RR, Ferrari MD, van den Maagdenberg AM. Molecular genetics of migraine. Hum Genet. 2009;12:115–32.
   Google Scholar
• Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988;16:1215.
   PubMed Web of Science ®Google Scholar
• Alasehirli B, Balat A, Barlas O, Kont A. Nitric oxide synthase gene polymorphisms in children with minimal change nephrotic syndrome. Pediatr Int. 2009;51:75–8.
   PubMedGoogle Scholar
• Johnson MP, Lea RA, Colson NJ, Macmillan JC, Griffiths LR. A population genomics overview of the neuronal nitric oxide synthase (nNOS) gene and its relationship to migraine susceptibility. Cell Mol Biol. (Noisy-le-grand) 2005;51:285–92.
   PubMedGoogle Scholar
• Li C, Hu Z, Liu Z, Wang LE, Gershenwald JE, Lee JE, Prieto VG, Duvic M, Grimm EA, Wei Q. Polymorphisms of the neuronal and inducible nitric oxide synthase genes and the risk of cutaneous melanoma: a case-control study. Cancer. 2007;109:1570–8.
   PubMedGoogle Scholar
• Saur D, Vanderwinden JM, Seidler B, Schmid RM, De Laet MH, Allescher HD. Single-nucleotide promoter polymorphism alters transcription of neuronal nitric oxide synthase exon 1c in infantile hypertrophic pyloric stenosis. Proc Natl Acad Sci. U S A. 2004;101:1662–7.
   PubMedGoogle Scholar
• Yu YW, Chen TJ, Wang YC, Liou YJ, Hong CJ, Tsai SJ. Association analysis for neuronal nitric oxide synthase gene polymorphism with major depression and fluoxetine response. Neuropsychobiology. 2003;47:137–40.
   PubMedGoogle Scholar
• Shinkai T, Ohmori O, Hori H, Nakamura J. Allelic association of the neuronal nitric oxide synthase (NOS1) gene with schizophrenia. Mol Psychiatry. 2002;7:560–3.
   PubMedGoogle Scholar
• de O S Mansur T, Gonçalves FM, Martins-Oliveira A, Speciali JG, Dach F, Lacchini R, Tanus-Santos JE. Inducible nitric oxide synthase haplotype associated with migraine and aura. Mol Cell Biochem. 2012;364:303–8.
   PubMedGoogle Scholar
• Gonçalves FM, Martins-Oliveira A, Speciali JG, Luizon MR, Izidoro-Toledo TC, Silva PS, Dach F, Tanus-Santos JE. Endothelial nitric oxide synthase haplotypes associated with aura in patients with migraine. DNA Cell Biol. 2011;30:363–9.
   PubMedGoogle Scholar
• Ciancarelli I, Tozzi-Ciancarelli MG, Di Massimo C, Marini C & Carolei A. Urinary nitricoxide metabolites and lipid peroxidation by-products in migraine. Cephalalgia. 2003;23:39–42.
   PubMedGoogle Scholar
• Lassen LH, Ashina M, Christiansen I, Ulrich V, Olesen J. Nitric oxide synthase inhibition in migraine. Lancet. 1997;349: 401–2.
   PubMedGoogle Scholar
• Lassen LH, Christiansen I, Iversen HK, Jansen-Olesen I, Olesen J. The effect of nitric oxide synthase inhibition on histamine induced headache and arterial dilatation in migraineurs. Cephalalgia. 2003;23:877–86.
   PubMedGoogle Scholar
• Stepien A, Chalimoniuk M. Level of nitric oxide-dependent cGMP in patients with migraine. Cephalalgia. 1998;18:631–4.
   PubMedGoogle Scholar
• Shimomura T, Murakami F, Kotani K, Ikawa S, Kono S. Platelet nitric oxide metabolites in migraine. Cephalalgia. 1999;19:218–22.
   PubMedGoogle Scholar
• Stirparo G, Zicari A, Favilla M, Lipari M, Martelletti P. Linked activation of nitric oxide synthase and cyclooxygenase in peripheral monocytes of asymptomatic migraine without aura patients. Cephalalgia. 2000;20:100–6.
   PubMedGoogle Scholar
• Charles A. Advances in the basic and clinical science of migraine. Ann Neurol. 2009;65: 491–8.
   PubMedGoogle Scholar